Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Tech trends to watch out for in pharma industry
Divay Kumar, CEO and co-founder, O4S, explains the various developments that have transformed, and trends that will transform, the…
Zydus receives final approval from US FDA for Vigabatrin tablets
Vigabatrin is used to treat babies, one month to two years old with infantile spasms
Syngene reports 10 per cent growth in revenue from operations
Growth in profit after tax was impacted by a lower effective tax rate in the third quarter last year due to a tax reversal and…
Scientists demonstrate utility of bilateral tumour model for evaluating anti-cancer T-cell responses
A temporal analysis of T-Cell Receptors (TCRs) can be used to track changes in tumour-reactive T-cells of cancer patients…
Mankind Pharma forays into critical care, launches division for life-saving injectables
With the launch, the company aspires to aid the community in leading a healthy life by formulating, developing, commercialising…
Ascletis announces signing of Ritonavir tablet purchase agreement with Phokam Pharmaceutical
Ritonavir oral tablet is a component of oral antiviral drug Paxlovid
Lupin signs first partnership agreement with Foncoo for China
This is Lupin’s first partnership arrangement in China and reinforces its commitment to bring high-quality generic and complex…
Pfizer shares in-vitro efficacy of novel COVID-19 oral treatment against Omicron
The in-vitro studies suggest that Paxlovid has the potential to maintain plasma concentrations many-fold times higher than the…
Merck allocates three million courses of Molnupiravir to be provided in first half of 2022 for use…
Merck is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics and it has been authorised for use in more than…
Fourth COVID vaccine partially effective against Omicron: Israeli study
The yet-to-be peer-reviewed study tested the efficacy and safety of vaccines and analysed whether the combination of vaccines from…